This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Finance & Accounting for Bioscience Companies
September 18-19, 2024
Omni Boston Hotel at the SeaportBoston, MA

Kyle Breidenstine
Vice President, Finance & Controller at PepGen


Kyle Breidenstine serves as Vice President, Finance & Controller at PepGen. Kyle played a key role in PepGen’s initial public offering, and he has led the finance team’s transition to a public company, including the build-out of the accounting, public company reporting, and FP&A functions. Prior to PepGen, Kyle held roles of increasing responsibility with the finance group at Orchard Therapeutics, where he was a key partner in the Company’s IPO and multiple successful equity offerings. Kyle became a CPA in 2012 and worked in the PwC assurance practice, supporting public and private clients in the biotech and healthcare industries. He began his career in finance working as a budget analyst for the Commonwealth of Massachusetts.

Agenda Sessions

  • Scaling for Growth: Architectural Development Benefitting Companies as they Mature